On behalf of GlaxoSmithKline (GSK), the ICSF has undertaken the first ever global in-depth study to identify healthcare innovations in developing countries that have the potential to be replicated to increase access to affordable medicine. The report assesses over 900 healthcare programmes for their suitability for investment to scale up and replicate elsewhere. It identifies significant opportunities for commercial organisations to establish strategic partnerships with a number of promising healthcare delivery models in order to drive scale, profitability and impact.
Articles and Blogs on the report
- Big Business and Healthcare: It’s not about the money - Andy Thornton – Stanford Social Innovation Review
- Where is the BoP healthcare fortune? - Andy Thornton – Stanford Social Innovation Review
- How to take projects to scale in developing countries - Dan Berelowitz – Guardian
Image courtesy of Afrikids